PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23391319-0	2013	The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.	lanthanum carbonate	45-64	fibroblast growth factor 23	Homo sapiens	68-73	
23391319-3	2013	The aim of this study is to compare the effectiveness of calcium carbonate vs. lanthanum carbonate in reducing serum FGF23 levels in Chronic Kidney Disease (CKD) patients.	lanthanum carbonate	79-98	fibroblast growth factor 23	Homo sapiens	117-122	
23391319-7	2013	RESULTS: As compared with calcium carbonate, patients on lanthanum carbonate had lower serum levels of FGF23 (226 +- 11 vs. 158 +- 9 pg/ml) and less urinary excretion of phosphate.	lanthanum carbonate	57-76	fibroblast growth factor 23	Homo sapiens	103-108	
23391319-9	2013	CONCLUSIONS: In conclusion, in CKD 4 - 5 patients lanthanum carbonate is effective in reducing phosphate load and FGF23 levels; this effect was not observed with calcium carbonate.	lanthanum carbonate	50-69	fibroblast growth factor 23	Homo sapiens	114-119